跳到正文
openFDA 已分级药品召回执法报告·· 19 天前AI 评分56

FDA 执法报告 D-0073-2027:Ritedose 富马酸福莫特罗吸入溶液因杂质/降解规格不合格列为 II 类召回

FDA drug enforcement D-0073-2027: The Ritedose Corporation — Failed Impurities/Degradation Specification

AI 导读

FDA 执法报告 D-0073-2027 记录 The Ritedose Corporation 对批号 25BL0 的富马酸福莫特罗吸入溶液(20mcg/2mL)发起 II 类自愿召回,原因为杂质/降解规格不合格。

正文 · 原文

FDA drug recall enforcement report — D-0073-2027

Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "1 Technology Cir",

"address_2": "",

"center_classification_date": "20261023",

"city": "Columbia",

"classification": "Class II",

"code_info": "Lot: 25BL0, Expires: 02/28/2027",

"country": "United States",

"distribution_pattern": "Nationwide within the U.S",

"event_id": "100124",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"ANDA216486"

],

"brand_name": [

"FORMOTEROL FUMARATE INHALATION SOLUTION"

],

"generic_name": [

"FORMOTEROL FUMARATE DIHYDRATE"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"Ritedose Pharmaceuticals, LLC"

],

"package_ndc": [

"76204-030-02",

"76204-030-01"

],

"product_ndc": [

"76204-030"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"RESPIRATORY (INHALATION)"

],

"rxcui": [

"1246319"

],

"spl_id": [

"459f276c-d771-4ae9-e063-6394a90a3476"

],

"spl_set_id": [

"2d9bf685-8886-4865-834b-2748af124b79"

],

"substance_name": [

"FORMOTEROL FUMARATE"

],

"unii": [

"W34SHF8J2K"

]

},

"postal_code": "29203-9591",

"product_description": "Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC",

"product_quantity": "3210 Cartons",

"product_type": "Drugs",

"reason_for_recall": "Failed Impurities/Degradation Specification",

"recall_initiation_date": "20261015",

"recall_number": "D-0073-2027",

"recalling_firm": "The Ritedose Corporation",

"report_date": "20261104",

"state": "SC",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov